Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrabdominal Hyperthermic Chemotherapy Using Gemcitabine to Treat Pancreatic Carcinomatosis

NCT03251365 is registered in ClinicalTrials.gov with Hospital General de Ciudad Real as lead sponsor.

NCT NCT03251365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03251365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrabdominal Hyperthermic Chemotherapy Using Gemcitabine to Treat Pancreatic Carcinomatosis
Lead sponsor
Hospital General de Ciudad Real
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 27, 2017
Completion date
December 31, 2024
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resectable pancreatic adenocarcinoma